[Helicobacter pylori: bacteriological aspects, diagnostic methods, and susceptibility to antibiotics]

Francis Mégraud1

  • 1Inserm U853, F-33076 Bordeaux Cedex, France. francis.megraud@chu-bordeaux.fr

Presse Medicale (Paris, France : 1983)
|February 12, 2008
PubMed

Insights

Helicobacter pylori, a common gut bacterium, requires specific diagnostic approaches. Reliable detection involves respiratory tests and serology, especially with proton pump inhibitor use. Macrolide resistance necessitates susceptibility testing before prescribing clarithromycin.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Gastroenterology

Background:

  • Helicobacter pylori is a recently discovered bacterium colonizing human and animal mucosa.
  • Acquisition of the cag pathogenicity island is crucial for its pathogenic role.
  • Understanding H. pylori's epidemiology and pathogenesis is vital for effective management.

Purpose of the Study:

  • To review diagnostic methods for Helicobacter pylori infection.
  • To highlight the importance of susceptibility testing for clarithromycin.
  • To emphasize reliable diagnostic strategies in clinical practice.

Main Methods:

  • Review of current diagnostic techniques for H. pylori.
  • Discussion of the reliability of respiratory tests and serology.
  • Emphasis on macrolide susceptibility testing (culture or molecular methods).

Main Results:

  • The respiratory test is identified as the most reliable diagnostic method.
  • Serology is a valuable tool, particularly for patients using proton pump inhibitors.
  • Macrolide resistance is prevalent, making susceptibility testing essential.

Conclusions:

  • Accurate diagnosis of H. pylori infection requires a combination of methods.
  • Respiratory testing and serology offer reliable diagnostic options.
  • Pre-treatment macrolide susceptibility testing is crucial to overcome clarithromycin resistance.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...